Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
Study Number: 

NCG 217112

Phase: 
III
Trial categories: 
Pediatric Cancers
Acute Myeloid Leukemia (AML)
Leukemia
Leukemia
Principal Investigator: